Soligenix, Inc. (SNGX): Price and Financial Metrics


Soligenix, Inc. (SNGX): $0.56

-0.02 (-2.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SNGX Stock Summary

  • SNGX has a higher market value than only 8.28% of US stocks; more precisely, its current market capitalization is $24,207,281.
  • SNGX's went public 28.68 years ago, making it older than 78.04% of listed US stocks we're tracking.
  • With a price/sales ratio of 28.2, SOLIGENIX INC has a higher such ratio than 95.4% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SOLIGENIX INC are PALT, VAXX, SINT, OCFT, and FEMY.
  • Visit SNGX's SEC page to see the company's official filings. To visit the company's web site, go to www.soligenix.com.

SNGX Valuation Summary

  • SNGX's EV/EBIT ratio is -1.2; this is 113.95% lower than that of the median Healthcare stock.
  • SNGX's price/sales ratio has moved NA NA over the prior 243 months.

Below are key valuation metrics over time for SNGX.

Stock Date P/S P/B P/E EV/EBIT
SNGX 2022-11-25 29.3 24.3 -1.7 -1.2
SNGX 2022-11-23 29.3 24.3 -1.7 -1.2
SNGX 2022-11-22 29.3 24.3 -1.7 -1.2
SNGX 2022-11-21 31.6 26.3 -1.8 -1.4
SNGX 2022-11-18 32.8 27.2 -1.9 -1.4
SNGX 2022-11-17 32.8 27.2 -1.9 -1.4

SNGX Growth Metrics

    Its 2 year revenue growth rate is now at -80.39%.
  • Its 2 year cash and equivalents growth rate is now at 217.57%.
  • The year over year revenue growth rate now stands at -45.36%.
SNGX's revenue has moved down $9,570,240 over the prior 67 months.

The table below shows SNGX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 0.878554 -11.86238 -15.02721
2022-03-31 0.864738 -10.99324 -14.53752
2021-12-31 0.824268 -11.73962 -12.55097
2021-09-30 0.869409 -12.80922 -13.38736
2021-06-30 1.292022 -12.76004 -11.58997
2021-03-31 1.582486 -12.74458 -12.46967

SNGX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNGX has a Quality Grade of F, ranking ahead of 4.48% of graded US stocks.
  • SNGX's asset turnover comes in at 0.055 -- ranking 317th of 682 Pharmaceutical Products stocks.
  • AVDL, OTIC, and ICPT are the stocks whose asset turnover ratios are most correlated with SNGX.

The table below shows SNGX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.055 0.261 -2.934
2021-03-31 0.082 0.296 -9.045
2020-12-31 0.171 0.228 13.842
2020-09-30 0.253 0.205 4.321
2020-06-30 0.353 0.185 4.346
2020-03-31 0.502 0.213 4.558

SNGX Price Target

For more insight on analysts targets of SNGX, see our SNGX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.88 Average Broker Recommendation 1.75 (Moderate Buy)

SNGX Stock Price Chart Interactive Chart >

Price chart for SNGX

SNGX Price/Volume Stats

Current price $0.56 52-week high $1.00
Prev. close $0.58 52-week low $0.38
Day low $0.55 Volume 98,400
Day high $0.58 Avg. volume 215,029
50-day MA $0.60 Dividend yield N/A
200-day MA $0.66 Market Cap 24.21M

Soligenix, Inc. (SNGX) Company Bio


Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.


SNGX Latest News Stream


Event/Time News Detail
Loading, please wait...

SNGX Latest Social Stream


Loading social stream, please wait...

View Full SNGX Social Stream

Latest SNGX News From Around the Web

Below are the latest news stories about SOLIGENIX INC that investors may wish to consider to help them evaluate SNGX as an investment opportunity.

UPDATE: Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat with PCG Advisory

UPDATE: Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat with PCG Advisory

Yahoo | November 16, 2022

Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat With PCG Advisory

Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat With PCG Advisory

Yahoo | November 16, 2022

Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received preliminary approval for a tax credit from the New Jersey Economic Development Authority's (NJEDA) New Jersey Technology Business Tax Certificate Transfer program. As a result, the Company anticipates being able to transfer this credit and receive appro

Yahoo | November 15, 2022

SNGX: HyBryte™ NDA to be Submitted Before the End of 2022…

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update HyBryte™ NDA Anticipated Before the End of 2022 Soligenix, Inc. (NASDAQ:SNGX) previously completed a Phase 3 clinical trial of HyBryte™ (SGX301, synthetic hypericin) in patients with cutaneous T cell lymphoma (CTCL). The FLASH ( Fl uorescent L ight A ctivated S ynthetic H ypericin) trial was a randomized, double

Yahoo | November 14, 2022

Soligenix Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

Soligenix ( NASDAQ:SNGX ) Third Quarter 2022 Results Key Financial Results Net loss: US$3.31m (loss narrowed by 7.8...

Yahoo | November 13, 2022

Read More 'SNGX' Stories Here

SNGX Price Returns

1-mo -15.80%
3-mo -22.22%
6-mo -0.05%
1-year -30.00%
3-year -44.55%
5-year -72.55%
YTD -15.19%
2021 -48.41%
2020 -11.72%
2019 68.60%
2018 -61.26%
2017 -1.33%

Continue Researching SNGX

Want to see what other sources are saying about Soligenix Inc's financials and stock price? Try the links below:

Soligenix Inc (SNGX) Stock Price | Nasdaq
Soligenix Inc (SNGX) Stock Quote, History and News - Yahoo Finance
Soligenix Inc (SNGX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8538 seconds.